501
Views
5
CrossRef citations to date
0
Altmetric
REVIEW

Telemedicine as a Tool to Improve Medicine Adherence in Patients with Affective Disorders – A Systematic Literature Review

ORCID Icon, ORCID Icon, ORCID Icon, &
Pages 3441-3463 | Received 02 Sep 2022, Accepted 17 Dec 2022, Published online: 30 Dec 2022

References

  • Andlin-Sobocki P, Jönsson B, Wittchen H-U, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol. 2005;12(s1):1–27. doi:10.1111/j.1468-1331.2005.01202.x
  • Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21(2):10. doi:10.1007/s11920-019-0997-0
  • World Health Organization. Defining Adherence. Adherence to long-term therapies: Evidence for action; 2003.
  • Lacro JP, Dunn LB, Dolder CR, Jeste DV, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):15489. doi:10.4088/JCP.v63n1007
  • Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Syst Rev. 2020;9(1):1–18. doi:10.1186/s13643-020-1274-3
  • Lindström E, Bingefors K. Patient compliance with drug therapy in schizophrenia. Pharmacoeconomics. 2000;18(2):105–124. doi:10.2165/00019053-200018020-00002
  • Ho SC, Chong HY, Chaiyakunapruk N, Tangiisuran B, Jacob SA. Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review. J Affect Disord. 2016;193:1–10. doi:10.1016/j.jad.2015.12.029
  • Wright EC. Non-compliance--or how many aunts has Matilda? Lancet. 1993;342(8876):909–913. doi:10.1016/0140-6736(93)91951-H
  • Vrijens B, de Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):15. doi:10.1111/j.1365-2125.2012.04167.x
  • Gilbert JR, Evans CE, Haynes RB, Tugwell P. Predicting compliance with a regimen of digoxin therapy in family practice. Can Med Assoc J. 1980;123(2):119–122.
  • Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. The rational clinical examination. Is this patient taking the treatment as prescribed? JAMA. 1993;269(21):2779–2781. doi:10.1001/jama.1993.03500210079036
  • Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983;13(1):177–183. doi:10.1017/S0033291700050182
  • Harvey NS. The development and descriptive use of the lithium attitudes questionnaire. J Affect Disord. 1991;22(4):211–219. doi:10.1016/0165-0327(91)90067-3
  • Horne R, Weinman J. The Beliefs About Medication Questionnaire: a new measure for assessing lay beliefs about medicines. BPS. 1995;1995:1.
  • Harvey NS, Summerton AM, Forrest AR, Peet M. Compliance, the LAQ, and a new laboratory method of measuring RBC lithium. J Clin Psychiatry. 1990;51(3):126–127.
  • Altamura AC, Mauri M. Plasma concentrations, information and therapy adherence during long-term treatment with antidepressants. Br J Clin Pharmacol. 1985;20(6):714–716. doi:10.1111/j.1365-2125.1985.tb05137.x
  • DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes a meta-analysis. Med Care. 2002;794–811. doi:10.1097/00005650-200209000-00009
  • Oller-Canet S, Fernández-San Martín MI, García-Lecina R, et al. Do depressed patients comply with treatments prescribed?: a cross-sectional study of adherence to the antidepressant treatment. Actas Esp Psiquiatr. 2011;39(5):288–293.
  • Åkerblad A-C, Bengtsson F, Holgersson M, von Knorring L, Ekselius L. Identification of primary care patients at risk of nonadherence to antidepressant treatment. Patient Prefer Adherence. 2008;2:379. doi:10.2147/ppa.s3511
  • Sajatovic M, Levin J, Fuentes-Casiano E, Cassidy KA, Tatsuoka C, Jenkins JH. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry. 2011;52(3):280–287. doi:10.1016/j.comppsych.2010.07.002
  • Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Human Psychopharmacol. 2008;23(2):95–105. doi:10.1002/hup.908
  • Jónsdóttir H, Opjordsmoen S, Birkenaes A, et al. Predictors of medication adherence in patients with schizophrenia and bipolar disorder. Acta Psychiatr Scand. 2013;127(1):23–33. doi:10.1111/j.1600-0447.2012.01911.x
  • Kirchner S-K, Lauseker M, Adorjan K, et al. Medication adherence in a cross-diagnostic sample of patients from the affective-to-psychotic spectrum: results from the PsyCourse study. Front Psychiatry. 2022;12:713060. doi:10.3389/fpsyt.2021.713060
  • Axelsson M, Brink E, Lundgren J, Lötvall J. The influence of personality traits on reported adherence to medication in individuals with chronic disease: an epidemiological study in West Sweden. PLoS One. 2011;6(3):e18241. doi:10.1371/journal.pone.0018241
  • Schulze LN, Stentzel U, Leipert J, et al. Improving medication adherence with telemedicine for adults with severe mental illness. Psychiatric Service. 2019;70(3):225–228. doi:10.1176/appi.ps.201800286
  • Dennis CL, Grigoriadis S, Zupancic J, Kiss A, Ravitz P. Telephone-based nurse-delivered interpersonal psychotherapy for postpartum depression: nationwide randomised controlled trial. Br J Psychiatry. 2020;216(4):189–196. doi:10.1192/bjp.2019.275
  • World Health Organization. Using e-health and information technology to improve health. Available from: https://www.who.int/westernpacific/activities/using-e-health-and-information-technology-to-improve-health. Accessed January 28, 2022.
  • Kapitel V; (DIMDI) DIfMDuI. Psychische und Verhaltensstörungen (F00-F99) ICD-10-GM Version 2018; 2017. Available from: https://www.dimdi.de/static/de/klassifikationen/icd/icd-10-gm/kode-suche/htmlgm2018/block-f30-f39.htm. Accessed June 23, 2020.
  • Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
  • Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods. 2006;5(1):80–92. doi:10.1177/160940690600500107
  • Gläser J, Laudel G. Expert Interviews and Qualitative Content Analysis: As Instruments for Reconstructive Investigations. Springer; 2009.
  • Higgins J, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.0. Cochrane; 2019. Available from: www.training.cochrane.org/handbook. Accessed December 19, 2022.
  • Kohl C, McIntosh EJ, Unger S, et al. Online tools supporting the conduct and reporting of systematic reviews and systematic maps: a case study on CADIMA and review of existing tools. Environ Evid. 2018;7(8):17.
  • Sterne J, Higgins J, Elbers R, Reeves B; And the development group for ROBINS-I. Risk of bias in non-randomized studies of interventions (ROBINS-I): detailed guidance; 2016; Available from: http://www.riskofbias.info. Accessed February 11, 2021.
  • Prictor M, Hill S. Cochrane Consumers and Communication Review Group: leading the field on health communication evidence. J Evid Based Med. 2013;6:5.
  • Ryan R. Cochrane consumers and communication review group: data synthesis and analysis; 2013.
  • Corden ME, Koucky EM, Brenner C, et al. MedLink: a mobile intervention to improve medication adherence and processes of care for treatment of depression in general medicine. Digital Health. 2016;2:2055207616663069. doi:10.1177/2055207616663069
  • Hammonds T, Rickert K, Goldstein C, et al. Adherence to antidepressant medications: a randomized controlled trial of medication reminding in college students. J Am Coll Health. 2015;63(3):204–208. doi:10.1080/07448481.2014.975716
  • Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Intern Med. 2017;177(5):624–631. doi:10.1001/jamainternmed.2016.9627
  • Aikens JE, Trivedi R, Heapy A, Pfeiffer PN, Piette JD. Potential impact of incorporating a patient-selected support person into mhealth for depression. J Gen Intern Med. 2015;30(6):797–803. doi:10.1007/s11606-015-3208-7
  • Gervasoni N, Legendre-Simon P, Aubry JM, Gex-Fabry M, Bertschy G, Bondolfi G. Early telephone intervention for psychiatric outpatients starting antidepressant treatment. Nord J Psychiatry. 2010;64(4):265–267. doi:10.3109/08039480903528641
  • Fortney JC, Pyne JM, Edlund MJ, et al. A randomized trial of telemedicine-based collaborative care for depression. J Gen Intern Med. 2007;22(8):1086–1093. doi:10.1007/s11606-007-0201-9
  • Salisbury C, O’Cathain A, Edwards L, et al. Effectiveness of an integrated telehealth service for patients with depression: a pragmatic randomised controlled trial of a complex intervention. Lancet Psychiatry. 2016;3(6):515–525. doi:10.1016/S2215-0366(16)00083-3
  • Hungerbuehler I, Valiengo L, Loch AA, Rössler W, Gattaz WF. Home-based psychiatric outpatient care through videoconferencing for depression: a randomized controlled follow-up trial. JMIR Mental Health. 2016;3(3):e36. doi:10.2196/mental.5675
  • Sajatovic M, Davis MS, Cassidy KA, Nestor J, Sams J, Fuentes-Casiano E. A technology-enabled adherence enhancement system for people with bipolar disorder: results from a feasibility and patient acceptance analysis. Patient Prefer Adherence. 2015;9:753–758. doi:10.2147/PPA.S81724
  • Lobban F, Dodd AL, Sawczuk AP, et al. Assessing feasibility and acceptability of web-based enhanced relapse prevention for bipolar disorder (erponline): a randomized controlled trial. J Med Internet Res. 2017;19(3):e85. doi:10.2196/jmir.7008
  • Levin JB, Sajatovic M, Rahman M, et al. Outcomes of psychoeducation and a text messaging adherence intervention among individuals with hypertension and bipolar disorder. Psychiatr Serv. 2019;70(7):608–612. doi:10.1176/appi.ps.201800482
  • Pauly A, Wolf C, Mayr A, Lenz B, Kornhuber J, Friedland K. Effect of a multi-dimensional and inter-sectoral intervention on the adherence of psychiatric patients. PLoS One. 2015;10(10). doi:10.1371/journal.pone.0139302
  • Gliddon E, Cosgrove V, Berk L, et al. A randomized controlled trial of MoodSwings 2.0: an internet-based self-management program for bipolar disorder. Bipolar Disord. 2019;21(1):28–39. doi:10.1111/bdi.12669
  • Himelhoch S, Medoff D, Maxfield J, et al. Telephone based cognitive behavioral therapy targeting major depression among urban dwelling, low income people living with HIV/AIDS: results of a randomized controlled trial. AIDS Behav. 2013;17(8):2756–2764. doi:10.1007/s10461-013-0465-5
  • Moore DJ, Poquette A, Casaletto KB, et al. Individualized Texting for Adherence Building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. AIDS Behav. 2015;19(3):459–471. doi:10.1007/s10461-014-0971-0
  • Cohen LB, Taveira TH, Wu WC, Pirraglia PA. Pharmacist-led telehealth disease management program for patients with diabetes and depression. J Telemed Telecare. 2020;26(5):294–302. doi:10.1177/1357633X18822575
  • Aikens JE, Rosland AM, Piette JD. Improvements in illness self-management and psychological distress associated with telemonitoring support for adults with diabetes. Prim Care Diabetes. 2015;9(2):127–134. doi:10.1016/j.pcd.2014.06.003
  • Merikangas KR, Jin R, J-P H, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241–251. doi:10.1001/archgenpsychiatry.2011.12
  • Lim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. 2018;8(1):1–10. doi:10.1038/s41598-018-21243-x
  • Levin JB, Krivenko A, Howland M, Schlachet R, Sajatovic M. Medication adherence in patients with bipolar disorder: a comprehensive review. CNS Drugs. 2016;30(9):819–835. doi:10.1007/s40263-016-0368-x
  • Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2008(2):5.
  • Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014(11). doi:10.1002/14651858.CD000011.pub4
  • Pelletier L, Shanmugasegaram S, Patten SB, Demers A. Self-management of mood and/or anxiety disorders through physical activity/exercise. Health Promot Chronic Dis Prev Can. 2017;37(5):149–159. doi:10.24095/hpcdp.37.5.03
  • Naslund JA, Marsch LA, McHugo GJ, Bartels SJ. Emerging mHealth and eHealth interventions for serious mental illness: a review of the literature. J Mental Health. 2015;24(5):321–332. doi:10.3109/09638237.2015.1019054
  • Lokkerbol J, Adema D, Cuijpers P, et al. Improving the cost-effectiveness of a healthcare system for depressive disorders by implementing telemedicine: a health economic modeling study. Am J Geriatr Psychiatry. 2014;22(3):253–262. doi:10.1016/j.jagp.2013.01.058
  • Yeung A, Martinson MA, Baer L, et al. The effectiveness of telepsychiatry-based culturally sensitive collaborative treatment for depressed Chinese American immigrants: a randomized controlled trial. J Clin Psychiatry. 2016;77(8):20755. doi:10.4088/JCP.15m09952
  • Chen JA, Chung W-J, Young SK, et al. COVID-19 and telepsychiatry: early outpatient experiences and implications for the future. Gen Hosp Psychiatry. 2020;66:89–95. doi:10.1016/j.genhosppsych.2020.07.002
  • Faurholt-Jepsen M, Frost M, Martiny K, et al. Reducing the rate and duration of Re-ADMISsions among patients with unipolar disorder and bipolar disorder using smartphone-based monitoring and treatment – the RADMIS trials: study protocol for two randomized controlled trials. Trials. 2017;18(1):277. doi:10.1186/s13063-017-2015-3
  • Kraft M, van den Berg N, Kraft K, et al. Development of a telemedical monitoring concept for the care of malnourished geriatric home-dwelling patients: a pilot study. Maturitas. 2012;72:126–131. doi:10.1016/j.maturitas.2012.02.011
  • van den Berg N, Schumann M, Kraft K, Hoffmann W. Telemedicine and telecare for older patients—A systematic review. Maturitas. 2012;2012(73 (2):94–114. doi:10.1016/j.maturitas.2012.06.010
  • Firet L, Teunissen D, Verhoeks C, Lagro-Janssen A. Expectations regarding eHealth among women with stress urinary incontinence. Int Urogynecol J. 2019;30(11):1955–1963. doi:10.1007/s00192-018-3849-2
  • Choi M. Association of eHealth use, literacy, informational social support, and health-promoting behaviors: mediation of health self-efficacy. Int J Environ Res Public Health. 2020;17(21):7890. doi:10.3390/ijerph17217890
  • Gentry MT, Lapid MI, Clark MM, Rummans TA. Evidence for telehealth group-based treatment: a systematic review. J Telemed Telecare. 2019;25(6):327–342. doi:10.1177/1357633X18775855
  • Aardoom JJ, Loheide-Niesmann L, Ossebaard HC, Riper H. Effectiveness of eHealth interventions in improving treatment adherence for adults with obstructive sleep apnea: meta-analytic review. J Med Internet Res. 2020;22(2):e16972. doi:10.2196/16972
  • Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatric Service. 1998;49(2):196–201. doi:10.1176/ps.49.2.196
  • Bulloch AG, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol. 2010;45(1):47–56. doi:10.1007/s00127-009-0041-5
  • Brueton VC, Tierney J, Stenning S, et al. Strategies to improve retention in randomised trials. Cochrane Database Syst Rev. 2013;2013(12):Mr000032.
  • Kemper CJ, Beierlein C, Bensch D, Kovaleva A, Rammstedt B. A short scale for measuring the gamma factor of socially desirable response behavior: the short scale Social Desirability-Gamma (KSE-G). GESIS-Working Papers. 2012;25:1–27.
  • Loughnan SA, Joubert AE, Grierson A, Andrews G, Newby JM. Internet-delivered psychological interventions for clinical anxiety and depression in perinatal women: a systematic review and meta-analysis. Arch Womens Ment Health. 2019;22(6):737–750. doi:10.1007/s00737-019-00961-9
  • Paulhus DL, Braun HI, Jackson DN, Wiley DE. Socially desirable responding: the evolution of a construct. In: The Role of Constructs in Psychological and Educational Measurement. Routledge; 2002;49459.
  • Szymczyńska P. Retention of Patients with Schizophrenia in Complex Intervention Trials: Patterns, Issues, and Practices. Queen Mary University of London; 2018.
  • Sedgwick P, Greenwood N. Understanding the Hawthorne effect. BMJ. 2015;351:h4672. doi:10.1136/bmj.h4672
  • Hughes DA. Medication adherence—Key considerations for clinical pharmacologists. Br J Clin Pharmacol. 2020;86(4):628. doi:10.1111/bcp.14228
  • Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatric Service. 2001;52(12):1615–1620. doi:10.1176/appi.ps.52.12.1615
  • Keyloun KR, Hansen RN, Hepp Z, Gillard P, Thase ME, Devine EB. Adherence and persistence across antidepressant therapeutic classes: a retrospective claims analysis among insured US patients with major depressive disorder (MDD). CNS Drugs. 2017;31(5):421–432. doi:10.1007/s40263-017-0417-0
  • Scott J. Predicting medication non-adherence in severe affective disorders. Acta neuropsychiatrica. 2000;12(3):128–130. doi:10.1017/S0924270800035584
  • Harvey NS, Peet M. Lithium maintenance: 2 effects of personality and attitude on health information acquisition and compliance. Br J Psychiatry. 2018;158(2):200–204.
  • Martinengo L, Stona A-C, Griva K, et al. Self-guided cognitive behavioral therapy apps for depression: systematic assessment of features, functionality, and congruence with evidence. J Med Internet Res. 2021;23(7):e27619. doi:10.2196/27619
  • Kay M, Santos J, Takane M. mHealth: new horizons for health through mobile technologies. World Health Organiz. 2011;64(7):66–71.
  • Marcoux RM, Vogenberg FR. Telehealth: applications from a legal and regulatory perspective. PT. 2016;41(9):567.
  • Stinson J, Wilson R, Gill N, Yamada J, Holt J. A systematic review of internet-based self-management interventions for youth with health conditions. J Pediatr Psychol. 2008;34(5):495–510. doi:10.1093/jpepsy/jsn115
  • Elnaem MH, Rosley NFF, Alhifany AA, Elrggal ME, Cheema E. Impact of pharmacist-led interventions on medication adherence and clinical outcomes in patients with hypertension and hyperlipidemia: a scoping review of published literature. J Multidiscip Healthc. 2020;13:635–645. doi:10.2147/JMDH.S257273
  • Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (Mars) for the psychoses. Schizophr Res. 2000;42(3):241–247. doi:10.1016/S0920-9964(99)00130-9
  • Mahler C, Hermann K, Horne R, et al. Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (Mars) in Germany. J Eval Clin Pract. 2010;16(3):574–579. doi:10.1111/j.1365-2753.2009.01169.x
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007